KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Amortization - Intangibles: 2013-2021

Historic Amortization - Intangibles for Aurinia Pharmaceuticals (AUPH) over the last 6 years, with Dec 2021 value amounting to $2.1 million.

  • Aurinia Pharmaceuticals' Amortization - Intangibles rose 25.63% to $500,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $2.1 million, marking a year-over-year increase of 57.99%. This contributed to the annual value of $2.1 million for FY2021, which is 61.54% up from last year.
  • Per Aurinia Pharmaceuticals' latest filing, its Amortization - Intangibles stood at $2.1 million for FY2021, which was up 61.54% from $1.3 million recorded in FY2020.
  • In the past 5 years, Aurinia Pharmaceuticals' Amortization - Intangibles ranged from a high of $2.1 million in FY2021 and a low of $1.1 million during FY2019.
  • Moreover, its 3-year median value for Amortization - Intangibles was $1.3 million (2020), whereas its average is $1.5 million.
  • As far as peak fluctuations go, Aurinia Pharmaceuticals' Amortization - Intangibles dropped by 12.46% in 2019, and later surged by 61.54% in 2021.
  • Yearly analysis of 4 years shows Aurinia Pharmaceuticals' Amortization - Intangibles stood at $1.3 million in 2018, then declined by 12.46% to $1.1 million in 2019, then increased by 14.24% to $1.3 million in 2020, then skyrocketed by 61.54% to $2.1 million in 2021.